Verastem reported $415K in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
AbbVie USD 645M 69M Mar/2026
Alaunos Therapeutics USD 1.07M 215K Jun/2023
AstraZeneca USD 484M 181M Dec/2025
Curis USD 178K 441K Dec/2023
Cytokinetics USD 33.34M 3M Mar/2026
Gilead Sciences USD 240M 15M Mar/2026
Incyte USD 569K 13K Mar/2026
Laboratory Of America USD 55.1M 100K Mar/2026
Novartis USD 343M 39M Mar/2026
Pfizer USD 671M 40M Mar/2026
Roche Holding CHF 304M 7.5M Jun/2025
TG Therapeutics USD 7.67M 1.13M Mar/2026
Verastem USD 415K 733K Dec/2025